查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1931246

全球侵入式餵食管市場（按管型、材質、最終用戶、年齡層和分銷管道分類）預測（2026-2032年）

Invasive Feeding Tube Market by Tube Type, Material, End User, Age Group, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，侵入性腸內營養管市場價值將達到 18.5 億美元，到 2026 年將成長至 19.4 億美元，到 2032 年將達到 26.8 億美元，複合年成長率為 5.40%。

關鍵市場統計數據
基準年 2025 18.5億美元
預計年份：2026年 19.4億美元
預測年份 2032 26.8億美元
複合年成長率 (%) 5.40%

本書全面介紹了侵入性鼻飼管技術、臨床決策路徑以及影響患者預後的跨專業連續性照護。

本執行摘要概述了侵入性餵食管的現狀，並將其置於現代醫療保健服務體系中，涵蓋了技術、臨床適應症和相關人員的責任等方面。摘要首先概述了器械類型和材質，重點介紹了選擇腸內營養途徑的臨床情況，並闡明了從外科醫生到居家照護協調員等多學科團隊的角色。預先建立這些基礎知識，能夠幫助讀者快速了解器械特性、手術選擇和病人預後之間的關聯。

臨床、材料和護理服務的變革性變化正在重新定義經腸營養程序的選擇、設備設計重點和醫療服務提供者的採購行為。

在臨床創新、監管力度加大以及醫療服務模式變革的推動下，侵入性餵食管領域正經歷變革性的轉變。微創技術和器材人體工學設計的進步，使得胃造瘻術和空腸造瘻術在各種醫療環境中都更加安全便捷。同時，聚氨酯和矽膠等材料的改進，也解決了生物相容性和耐用性方面的問題。此外，對以患者為中心的治療效果的日益重視，正在加速推廣那些強調降低併發症發生率和實現從醫院到居家照護平穩過渡的通訊協定。

2025年美國關稅調整如何重塑整個醫療保健領域的供應鏈、採購選擇、產品設計策略和採購趨勢

美國關稅的實施和調整將於2025年生效，這將對餵食管製造商、經銷商和醫療保健機構產生多方面的影響。關稅調整將改變整個供應鏈的成本結構，影響聚氨酯、聚氯乙烯和矽膠等常用聚合物的原料採購決策，並促使採購團隊重新評估供應商多元化和近岸外包策略。這些成本壓力將促使獎勵最佳化製造地、重新談判供應商契約，並專注於增強供應鏈韌性，以確保醫療機構醫療設備的穩定供應。

深度分割分析揭示了導管類型、材質、最終用戶、年齡層和通路如何決定臨床選擇和商業策略。

細分市場分析揭示了不同設備類型、材質、最終用戶、年齡層和通路之間的細微差別，這些因素都會導致不同的臨床和商業性考慮。就導管類型而言，胃造瘻管包括腹腔鏡輔助胃造瘻術、經皮視鏡胃造瘻術和放射引導下胃造瘻術等亞型，這些亞型在插入環境、對影像診斷的依賴程度以及對臨床醫生培訓的要求方面存在差異。同時，空腸造瘻術包括直接空腸造瘻術和經皮視鏡空腸造瘻術，其選擇取決於病患的生理狀況和營養目標。鼻十二指腸管和鼻胃管仍然是短期腸內營養的重要途徑，但與外科手術或放射引導下置入的導管相比，它們在耐受性和移位風險方面具有不同的特徵。

美洲、歐洲、中東和非洲以及亞太地區的區域差異影響著經腸營養產品的監管、採購和醫療保健服務重點。

區域趨勢差異顯著，美洲、歐洲、中東和非洲地區以及亞太地區在法規環境、醫療服務模式和採購慣例方面存在明顯差異。在美洲，完善的急診基礎設施以及不斷擴展的門診和居家醫療能力，催生了對可在醫院和社區環境中植入的醫療器材的需求。該地區的政策框架和報銷趨勢正在影響資本採購週期，獎勵企業採購能夠縮短住院時間和降低再入院風險的醫療器材。

主要企業的策略重點在於產品創新、綜合服務、醫療專業人員培訓和分銷模式，以確保永續的採購夥伴關係。

公司層面的活動反映了以產品創新、服務整合和通路最佳化為核心的多面向競爭。主要企業正投資於流程培訓、醫護人員支援和數位化工具，以期在治療效果而非價格方面脫穎而出。同時，小規模的專業製造商則專注於滿足特定的臨床需求，例如兒童尺寸或先進的固定系統。醫療設備製造商與服務供應商之間的策略聯盟正在興起，這些聯盟涵蓋包裝插入服務、遠端監測和維護通訊協定，旨在降低併發症發生率並提高患者滿意度。

為實現持續的臨床和採購價值，提供協調設備設計、臨床醫生教育、供應鏈韌性和商業策略的實用建議。

針對行業領導者的具體建議強調，產品設計、臨床支援和商業模式應務實地協調一致，以滿足不斷變化的相關人員的需求。首先，應優先開發兼顧臨床醫師效率和病患舒適度的器械，採用生物相容性和耐用性俱佳的材料，並考慮模組化設計，以便在供應緊張時進行組件級替換。此外，還應透過全面的臨床醫生培訓計劃、基於模擬的認證以及清晰的術後護理路徑來配合器械投資，從而降低併發症發生率並增強臨床信心。

調查方法將採用嚴格的混合方法，結合臨床訪談、文獻綜述、監管審查和供應鏈分析，以檢驗研究結果。

本調查方法採用混合方法，結合一手訪談、臨床文獻綜述、法規審查和供應鏈分析，以全面了解經皮鼻飼管的現況。一手研究包括對急診、門診和居家照護機構的臨床醫生、醫院和長期護理機構的採購主管以及醫療設備製造商和分銷商的高管進行結構化訪談，以深入了解臨床應用、採購標準和運營限制。這些定性研究結果與同行評審的臨床研究和法規指南進行檢驗，以確保其與實踐趨勢和實證最佳實踐相符。

一份權威的綜合報告，重點闡述了創新、供應鏈韌性和精準策略如何協同作用，從而改善臨床療效和採購成功率。

總之，經皮經腸營養管領域正處於臨床創新、醫療服務轉型和採購趨勢變化的交會點。技術和材料科學的進步使得更安全、更人性化的選擇成為可能，從而支持向門診和居家照護環境的過渡。同時，關稅和供應鏈壓力促使採購和生產方面進行策略調整。按管型、材質、最終用戶、年齡層和分銷管道進行細分，凸顯了根據特定臨床和採購需求客製化產品特性和商業性策略的重要性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 按管型分類的侵入性餵食管市場

  • 胃造瘻術
    • 腹腔鏡輔助胃造口術
    • 經皮視鏡胃造瘻術
    • 放射線引導下胃造瘻術
  • 空腸瘻管
    • 直接空腸造口手術
    • 經皮視鏡空腸造口術
  • 鼻十二指腸餵食管
  • 鼻胃管

9. 按材料分類的侵入式餵食管市場

  • 聚氨酯
  • 聚氯乙烯
  • 矽酮

第10章 依最終用戶分類的侵入式餵食管市場

  • 門診手術中心
  • 居家醫療
  • 醫院
  • 專科診所

第11章 依年齡層別分類的侵入性餵食管市場

  • 成人版
  • 老年人
  • 兒童

12. 按分銷管道分類的侵入式餵食管市場

  • 離線
  • 線上

13. 各地區侵入性餵食管市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 依組別分類的侵入性餵食管市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國侵入性餵食管市場概況

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國侵入式餵食管市場

第17章：中國侵入式餵食管市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Amsino International, Inc.
  • Angiplast Private Limited
  • Applied Medical Technology, Inc.
  • Avanos Medical, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Danone SA
  • Fresenius Kabi AG
  • Medela AG
  • Medinova Endosys Pvt. Ltd.
  • Moog, Inc.
  • Nestle Health Science SA
  • Poly Medicure Limited
  • Romsons Group
  • Vesco Medical
  • Vygon SA
Product Code: MRR-7B550E008DE2

The Invasive Feeding Tube Market was valued at USD 1.85 billion in 2025 and is projected to grow to USD 1.94 billion in 2026, with a CAGR of 5.40%, reaching USD 2.68 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.85 billion
Estimated Year [2026] USD 1.94 billion
Forecast Year [2032] USD 2.68 billion
CAGR (%) 5.40%

A definitive introduction framing invasive feeding tube technologies, clinical decision pathways, and the multidisciplinary care continuum shaping patient outcomes

This executive summary introduces the invasive feeding tube landscape by framing the technologies, clinical indications, and stakeholder responsibilities that define contemporary care delivery. The narrative begins with an overview of device types and materials, emphasizes the clinical contexts in which enteral access is chosen, and clarifies the roles of multidisciplinary teams from surgical specialists to home care coordinators. By establishing these fundamentals upfront, readers gain a concise orientation that links device attributes to procedural selection and patient outcomes.

Transitioning from fundamentals to context, the introduction also highlights how procedural techniques and care settings influence both short-term clinical success and long-term patient quality of life. It outlines the typical patient pathways for tube insertion, maintenance, and transition between acute, long-term, and home environments. This orientation primes decision-makers to appreciate the interplay between technology design, clinical workflow, and reimbursement environment, setting the stage for more detailed sections that analyze shifting market dynamics, tariff impacts, segmentation nuances, regional variations, and actionable recommendations for stakeholders.

Transformative clinical, material, and care delivery shifts that are redefining procedural choices, device design priorities, and provider procurement behaviors in enteral access

The landscape for invasive feeding tubes is experiencing transformative shifts driven by clinical innovation, regulatory scrutiny, and changing care delivery models. Advances in minimally invasive techniques and device ergonomics are making gastrostomy and jejunostomy procedures safer and more accessible in a broader range of settings, while improvements in materials such as polyurethane and silicone are addressing both biocompatibility and longevity concerns. Simultaneously, heightened focus on patient-centered outcomes has accelerated adoption of protocols that emphasize reduced complication rates and streamlined transitions from hospital to home care.

Beyond clinical and material innovations, regulatory frameworks and procurement behaviors are evolving in ways that favor standardized training, validated insertion techniques, and robust post-procedural support. These shifts are prompting manufacturers to rethink design-for-serviceability and to invest in clinician education and remote support capabilities. Concurrently, the growth of ambulatory surgical centers and home healthcare services is reshaping where enteral access is provided, creating demand for devices optimized for outpatient insertion and simplified maintenance. Together, these forces are reallocating value across stakeholders and redefining competitive priorities for product developers, healthcare providers, and payers.

How adjusted United States tariffs in 2025 are reshaping supply chains, sourcing choices, product engineering strategies, and procurement dynamics across the care continuum

In 2025 the imposition and recalibration of United States tariffs will have multilayered implications for manufacturers, distributors, and care providers involved with invasive feeding tubes. Tariff adjustments alter cost structures across the supply chain, influencing raw material sourcing decisions for common polymers such as polyurethane, polyvinyl chloride, and silicone, and prompting procurement teams to reassess supplier diversification and nearshoring strategies. These cost pressures create operational incentives to optimize manufacturing footprints, to renegotiate supplier contracts, and to increase emphasis on supply chain resilience in order to maintain consistent device availability across care settings.

Concurrently, tariff-driven changes may catalyze product-level responses such as reengineering device components to reduce reliance on taxed inputs, or accelerating the adoption of locally produced alternatives where feasible. For healthcare providers, particularly hospitals and long-term care facilities that operate within constrained budgets, these shifts can influence purchasing cycles and vendor consolidation decisions. In turn, distributors and original equipment manufacturers may respond by enhancing bundled service offerings, extending payment terms, or emphasizing value-based outcomes that justify incremental cost. Importantly, policy-induced cost dynamics reinforce the need for transparent total-cost-of-ownership conversations between suppliers and health systems, and for strategic planning that anticipates regulatory and trade volatility.

Deep segmentation analysis revealing how tube type, material, end user, age group, and distribution pathways together determine clinical selection and commercial strategy

Segmentation insights reveal nuanced dynamics across device types, materials, end users, age groups, and distribution channels, each of which drives distinct clinical and commercial considerations. Within tube type, gastrostomy devices encompass laparoscopic assisted gastrostomy, percutaneous endoscopic gastrostomy, and radiologically inserted gastrostomy subtypes that differ in insertion setting, imaging reliance, and clinician training requirements, while jejunostomy options include both direct jejunostomy and percutaneous endoscopic jejunostomy pathways that are selected based on patient physiology and nutritional goals. Nasoduodenal and nasogastric tubes remain essential for short-term enteral access but present distinct tolerability and displacement risk profiles compared with surgically or radiologically inserted devices.

Material selection also profoundly affects performance and clinical preference, with polyurethane and silicone favored for their flexibility and biocompatibility and polyvinyl chloride used where cost and stiffness considerations dominate. End user segmentation highlights divergent procurement and utilization patterns between ambulatory surgical centers, home healthcare providers, hospitals-including community, secondary care, and tertiary care hospitals-long term care facilities, and specialty clinics, each setting imposing unique requirements for device robustness, clinician skillsets, and aftercare infrastructure. Age group distinctions across adult, geriatric, and pediatric cohorts necessitate design adaptations for size, anchoring, and tolerability, and distribution channels ranging from direct sales through original equipment manufacturers and third party distributors to hospital pharmacies, online pharmacies, and retail pharmacies shape availability, pricing, and the buyer journey. Together, these segmentation layers inform targeted product development, tailored training programs, and differentiated commercial strategies that align device attributes with real-world clinical and procurement demands.

Regional differentiation across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping regulatory, procurement, and care delivery priorities for enteral access products

Regional dynamics vary considerably and meaningful differentiation emerges when contrasting the Americas, Europe, Middle East & Africa, and Asia-Pacific in terms of regulatory environments, care delivery models, and procurement practices. The Americas exhibit robust acute care infrastructure with growing outpatient and homecare capabilities, creating demand for devices optimized for both hospital and community-based insertion. Policy frameworks and reimbursement trends in this region influence capital procurement cycles and create incentives for devices that reduce length of stay and readmission risks.

Europe, the Middle East & Africa present a heterogeneous landscape where regulatory harmonization in some markets contrasts with fragmented procurement in others, and where public health priorities shape adoption curves. In parts of EMEA, constrained budgets and a larger public healthcare footprint drive emphasis on cost-effective, durable devices and centralized purchasing. The Asia-Pacific region displays rapid hospital expansion, growing investment in minimally invasive procedures, and increasing local manufacturing capacity, which together accelerate uptake but also heighten price sensitivity and competition. Transitions across these regions are influenced by demographic trends such as aging populations, differential prevalence of chronic conditions requiring long-term enteral nutrition, and regional strategies to strengthen outpatient care pathways, all of which inform prioritized market approaches and regional commercialization planning.

Key company strategies emphasizing product innovation, integrated services, clinician training, and distribution models to secure durable procurement partnerships

Company-level activity reflects multifaceted competition focused on product innovation, service integration, and channel optimization. Leading firms are investing in procedural training, clinician support, and digital tools to differentiate on outcomes rather than price alone, and smaller specialized manufacturers are positioning around niche clinical needs such as pediatric sizing or advanced anchoring systems. Strategic partnerships between device producers and service providers are emerging to bundle insertion services, remote monitoring, and maintenance protocols, with an emphasis on reducing complication rates and enhancing patient satisfaction.

In parallel, commercial strategies increasingly prioritize direct engagement with hospitals and integrated delivery networks while also nurturing relationships with ambulatory surgical centers and home care organizations. Distribution models are evolving to include combinations of direct sales by original equipment manufacturers and third party distribution agreements that ensure wider geographic coverage. Companies that can demonstrate robust clinician training programs, validated safety profiles, and post-market surveillance capabilities will be better positioned to secure long-term procurement contracts. Additionally, investments in local manufacturing or regional partnerships can mitigate tariff and supply chain risks, enabling more resilient service delivery across diverse healthcare ecosystems.

Practical recommendations for aligning device design, clinician education, supply chain resilience, and commercial strategy to capture sustained clinical and procurement value

Actionable recommendations for industry leaders emphasize pragmatic alignment of product design, clinical support, and commercial models to address evolving stakeholder priorities. First, prioritize developing devices that balance clinician ergonomics with patient comfort, leveraging materials that optimize biocompatibility and durability while considering modular design to enable component-level substitution when supply constraints arise. Complement device investments with comprehensive clinician training programs, simulation-based credentialing, and clear post-procedural care pathways to lower complication rates and to build clinical trust.

Second, strengthen supply chain resilience by diversifying sourcing, evaluating nearshoring options, and building contingency inventories for critical components. Engage procurement teams proactively to create value-based contracting frameworks that link device selection to measurable clinical outcomes. Third, tailor go-to-market approaches by aligning distribution strategies to end user needs-direct sales and OEM partnerships for large hospital systems, and streamlined packaging and remote support for ambulatory and home care settings. Finally, invest in regional intelligence and localized partnerships to navigate regulatory nuances across the Americas, Europe, Middle East & Africa, and Asia-Pacific, thereby reducing market entry friction and enhancing responsiveness to tariff or policy shifts. Implementing these steps will position organizations to deliver clinical value while maintaining commercial agility.

A rigorous mixed-methods research approach combining primary clinical interviews, literature synthesis, regulatory review, and supply chain mapping to validate findings

The research methodology integrates a mixed-methods approach combining primary interviews, clinical literature synthesis, regulatory review, and supply chain analysis to construct a robust view of the invasive feeding tube environment. Primary research included structured interviews with clinicians across acute, ambulatory, and home care settings, procurement leaders in hospitals and long term care facilities, and executives from device manufacturers and distributors to capture perspectives on clinical use, purchasing considerations, and operational constraints. These qualitative insights were triangulated with peer-reviewed clinical studies and regulatory guidance to ensure alignment between practice trends and evidence-based best practices.

Supplementing the primary and literature work, the methodology incorporated an examination of material science literature to assess polymer performance attributes and a review of trade and policy documents to identify recent tariff and procurement developments. Supply chain mapping exercises traced common sourcing pathways for key components, and comparative analyses across regions elucidated how regulatory, demographic, and care delivery differences shape adoption. Throughout the process, data quality checks and respondent triangulation were applied to validate findings and to ensure that conclusions reflect widely observed patterns rather than isolated anecdotes.

A conclusive synthesis highlighting how innovation, supply chain resilience, and targeted strategies converge to improve clinical outcomes and procurement success

In conclusion, the invasive feeding tube sector sits at the intersection of clinical innovation, care delivery transformation, and shifting procurement dynamics. Advances in procedural techniques and material science are enabling safer, more patient-friendly options that support transitions into outpatient and home care environments, while tariff and supply chain pressures are prompting strategic adjustments in sourcing and manufacturing. Segmentation by tube type, material, end user, age group, and distribution channel underscores the importance of tailoring product features and commercial approaches to specific clinical and procurement needs.

Looking ahead, organizations that integrate strong clinician education programs, resilient supply chains, and targeted regional strategies will be best positioned to deliver measurable clinical value and to capture sustainable commercial opportunity. The convergence of innovation and operational discipline offers a pathway to reduce complications, improve patient experiences, and align product economics with stakeholder expectations. Stakeholders that proactively adapt to these realities-by refining device design, strengthening post-market support, and optimizing distribution models-will contribute to improved patient outcomes and to more efficient care delivery across diverse healthcare settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Invasive Feeding Tube Market, by Tube Type

  • 8.1. Gastrostomy
    • 8.1.1. Laparoscopic Assisted Gastrostomy
    • 8.1.2. Percutaneous Endoscopic Gastrostomy
    • 8.1.3. Radiologically Inserted Gastrostomy
  • 8.2. Jejunostomy
    • 8.2.1. Direct Jejunostomy
    • 8.2.2. Percutaneous Endoscopic Jejunostomy
  • 8.3. Nasoduodenal
  • 8.4. Nasogastric

9. Invasive Feeding Tube Market, by Material

  • 9.1. Polyurethane
  • 9.2. Polyvinyl Chloride
  • 9.3. Silicone

10. Invasive Feeding Tube Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Home Healthcare
  • 10.3. Hospitals
  • 10.4. Specialty Clinics

11. Invasive Feeding Tube Market, by Age Group

  • 11.1. Adult
  • 11.2. Geriatric
  • 11.3. Pediatric

12. Invasive Feeding Tube Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Invasive Feeding Tube Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Invasive Feeding Tube Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Invasive Feeding Tube Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Invasive Feeding Tube Market

17. China Invasive Feeding Tube Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Amsino International, Inc.
  • 18.7. Angiplast Private Limited
  • 18.8. Applied Medical Technology, Inc.
  • 18.9. Avanos Medical, Inc.
  • 18.10. B. Braun Melsungen AG
  • 18.11. Becton, Dickinson and Company
  • 18.12. Boston Scientific Corporation
  • 18.13. Cardinal Health, Inc.
  • 18.14. Cook Medical LLC
  • 18.15. Danone S.A.
  • 18.16. Fresenius Kabi AG
  • 18.17. Medela AG
  • 18.18. Medinova Endosys Pvt. Ltd.
  • 18.19. Moog, Inc.
  • 18.20. Nestle Health Science S.A.
  • 18.21. Poly Medicure Limited
  • 18.22. Romsons Group
  • 18.23. Vesco Medical
  • 18.24. Vygon SA

LIST OF FIGURES

  • FIGURE 1. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INVASIVE FEEDING TUBE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INVASIVE FEEDING TUBE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES INVASIVE FEEDING TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA INVASIVE FEEDING TUBE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY LAPAROSCOPIC ASSISTED GASTROSTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY LAPAROSCOPIC ASSISTED GASTROSTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY LAPAROSCOPIC ASSISTED GASTROSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC GASTROSTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC GASTROSTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC GASTROSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY RADIOLOGICALLY INSERTED GASTROSTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY RADIOLOGICALLY INSERTED GASTROSTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY RADIOLOGICALLY INSERTED GASTROSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY DIRECT JEJUNOSTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY DIRECT JEJUNOSTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY DIRECT JEJUNOSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC JEJUNOSTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC JEJUNOSTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC JEJUNOSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY NASODUODENAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY NASODUODENAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY NASODUODENAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY NASOGASTRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY NASOGASTRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY NASOGASTRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS INVASIVE FEEDING TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. GCC INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 149. GCC INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 150. GCC INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. GCC INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GCC INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GCC INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. G7 INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. G7 INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 173. G7 INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 174. G7 INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 175. G7 INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. G7 INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. G7 INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. NATO INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. NATO INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NATO INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 181. NATO INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 182. NATO INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 183. NATO INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. NATO INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. NATO INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL INVASIVE FEEDING TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES INVASIVE FEEDING TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA INVASIVE FEEDING TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA INVASIVE FEEDING TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA INVASIVE FEEDING TUBE MARKET SIZE, BY GASTROSTOMY, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA INVASIVE FEEDING TUBE MARKET SIZE, BY JEJUNOSTOMY, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA INVASIVE FEEDING TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA INVASIVE FEEDING TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA INVASIVE FEEDING TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA INVASIVE FEEDING TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)